Cargando…
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
Evidence of significant hearing loss during the early days of use of cisplatin as a chemotherapeutic agent in cancer patients has stimulated research into the causes and treatment of this side effect. It has generally been accepted that hearing loss is produced by excessive generation of reactive ox...
Autores principales: | Sheth, Sandeep, Mukherjea, Debashree, Rybak, Leonard P., Ramkumar, Vickram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663723/ https://www.ncbi.nlm.nih.gov/pubmed/29163050 http://dx.doi.org/10.3389/fncel.2017.00338 |
Ejemplares similares
-
Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity
por: Ramkumar, Vickram, et al.
Publicado: (2021) -
Ototoxicity of Non-aminoglycoside Antibiotics
por: Rybak, Leonard P., et al.
Publicado: (2021) -
The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
por: Ghosh, Sumana, et al.
Publicado: (2018) -
Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss
por: Dhukhwa, Asmita, et al.
Publicado: (2021) -
Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity
por: Borse, Vikrant, et al.
Publicado: (2017)